| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
National Research Corp (NRC) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. NRC is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 172.0K | $3.18M | - | |
| COO | 140.5K | $2.60M | - | |
| VP | 100.0K | $1.85M | - | |
| Dir | 22.6K | $417.9K | - | |
| Dir | 22.6K | $417.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2018 | Nunnelly John N | Director | Sale+OE | 100 | $29.50 | $2,950.00 | -0.3% | |
| Mar 28, 2018 | Nunnelly John N | Director | Sale+OE | 4,068 | $28.87 | $117,440.72 | -12.4% | |
| Mar 27, 2018 | Nunnelly John N | Director | Sale+OE | 4,991 | $28.66 | $143,042.55 | -5.5% | |
| Mar 23, 2018 | Nunnelly John N | Director | Sale+OE | 356 | $30.15 | $10,732.00 | -0.4% | |
| Mar 21, 2018 | Nunnelly John N | Director | Sale+OE | 5,612 | $31.13 | $174,716.80 | -8.3% | |
| Mar 16, 2018 | Nunnelly John N | Director | Sale+OE | 2,383 | $31.74 | $75,642.14 | -7.7% | |
| Feb 15, 2018 | Hays Michael D. | CEO | Sell | 5,261,410 | $19.31 | $101,597,827.10 | -100% | |
| Feb 15, 2018 | Amandla Mk Trust69 | 10% Owner | Buy | 5,494,440 | $19.31 | $106,097,636.40 | New | |
| Jan 25, 2018 | Hays Michael D. | CEO | Sell | 1,602,399 | $39.03 | $62,541,632.97 | -100% | |
| Nov 1, 2017 | K/i/e/trust Under Agreement 3/9/09 | 10% Owner | Sell | 9,000 | $36.50 | $328,500.00 | -0.2% |